<DOC>
	<DOCNO>NCT00489333</DOCNO>
	<brief_summary>The purpose study compare effect supplementation ProAlgaZyme ( novel fermentation product freshwater algae ecosystem ) vs. placebo Metabolic Syndrome indicator cardiovascular health include : body weight fat , blood lipid , inflammatory marker hsCRP , blood pressure fast blood glucose .</brief_summary>
	<brief_title>ProAlgaZyme Novel Algae Infusion : Applications Metabolic Syndrome</brief_title>
	<detailed_description>Metabolic syndrome , set symptom strongly associate increase risk cardiovascular disease diabetes , generally link obesity become serious problem many industrialized country . Agents aid weight loss help normalize blood lipid inflammation may reduce risk metabolic syndrome therefore , reduce risk cardiovascular disease diabetes . This study single-center , double-blind , placebo-controlled , parallel design , evaluate effect ProAlgaZyme ( 4 fl . oz . daily ) metabolic syndrome marker cardiovascular health include blood lipid , inflammatory marker anthropometric measurement . Comparisons : ProAlgaZyme vs. placebo [ Time frame : 10 week ]</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<criteria>Participants must meet 3 follow criterion : BMI â‰¥30 kg/m2 HDL Cholesterol &lt; 40 Triglycerides &gt; 150 mg/dl Fasting blood glucose &gt; 100 mg/dl Blood pressure &gt; 130/85 mm Hg Total Cholesterol &gt; 200 mg/dl LDL Cholesterol &gt; 160 mg/dl Interleukin 6 ( IL6 ) &gt; 5pg/mL Morbidly obese : BMI &gt; 40 kg/m2 Taking cholesterollowering medication 30 day prior start enrollment course study . Enrolled another clinical study past 6 month . Pregnant , actively infect , medication interfere healing ( example , steroid ) , inflicted systemic disease AIDS , HIV , active hepatitis active malignancy ( clinical sign within past 5 year ) , suffer diabetes mellitus require daily insulin management .</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2007</verification_date>
	<keyword>ProAlgaZyme</keyword>
	<keyword>Metabolic syndrome</keyword>
	<keyword>Inflammation</keyword>
	<keyword>Cardiovascular</keyword>
	<keyword>hsCRP</keyword>
	<keyword>Lipids</keyword>
	<keyword>Algae</keyword>
</DOC>